Final Program

384 WEDNESDAY • MAY 18
P991
P992
P993
P994
P995
P996
P997
D54
The Prevalence of Vitamin D Deficiency in Pulmonary
Hypertension Patients and Its Correlation with Parameters of
Pulmonary Hypertension Severity/B. Tashtoush, J. Mehta, J.
Benavides, R. Memarpour, S. Kachur, J.B. Gleason, A. Hadeh, L.
Smolley, F.F. Rahaghi, Weston, FL, p.A7358
Determining the Role of Cardiac FDG Gated PET Scan for the
Assessment of Right Ventricular Size and Function in Patients
with Pulmonary Hypertension/D. Uzunaslan, M. Park, S.
Chirakarnjanakorn, C. Jellis, E.C. Roach, K.B. Highland, J.
Thomas, S.Y. Farha, S.C. Erzurum, W.H.W. Tang, D. Neumann, S.
Patel, F. DiFilippo, Cleveland, OH, p.A7359
Is Pulmonary Hypertension a Risk Factor for Arrhythmias? A
National Discharge Sample Study/S. Aggarwal, R. Loomba, N.
Gupta, V. Alla, R. Arora, R. Anderson, Omaha, NE, p.A7360
Pulmonary Arteriovenous Malformations in Non-Hereditary
Hemorrhagic Telangiectasia Patients: A 15 Year
Retrospective Study/J.M. Segraves, B.S. Pannu, V.N. Iyer,
Rochester, MN, p.A7361
Non-Invasive Estimation of Pulmonary Artery Wedge Pressure/
K. Zaki, X. Wang, R. Dweik, G.A. Heresi, Cleveland, OH, p.A7362
Non-Invasive Evaluation of Right Ventricular Function,
Pulmonary Vascular Hemodynamic and Ventilatory Efficiency
During Exercise in Pulmonary Arterial Hypertension and Heart
Failure/M. Vicenzi, G. Deboeck, V. Faoro, M. Cheli, S. Caravita, R.
Naeije, J.-L. Vachiery, Brussels, Belgium, p.A7363
The Effects of Combination Therapy on Clinical Worsening: A
Meta-Analysis/A.C. Lajoie, G. Lauziere, J.C. Lega, Y. Lacasse, S.
Martin, S. Simard, S. Bonnet, S. Provencher, Quebec City, Canada,
p.A7920
THEMATIC POSTER SESSION
CLINICAL PULMONARY HYPERTENSION
9:00 a.m. - 3:30 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area H, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P999
P1000
M.R. Lammi, MD, New Orleans, LA
The UK National Cohort Study of Idiopathic and Heritable
Pulmonary Arterial Hypertension/C. Treacy, M. Blenda, C.
Hadinnapola, M. Haimel, G. Coghlan, P.A. Corris, J.S. Gibbs, D.G.
Kiely, A. Lawrie, A.J. Peacock, J. Pepke-Zaba, R.C. Trembath, J.
Wharton, M.R. Wilkins, S.J. Wort, S. Graf, N.W. Morrell,
Cambridge, United Kingdom, p.A7364
New Approaches in Narrative Analysis Highlight Marked
Issues of Adaptation and Change for Patients with Pulmonary
Hypertension and Explore How Identity Is Modified in the
Context of Clinical Care/J. Goddard, I. Armstrong, B. Stone, I.
Sabroe, Sheffield, United Kingdom, p.A7365
P1001
P1002
P1003
P1004
P1005
P1006
P1007
P1008
P1009
P1010
Facilitator:
P1011
Limitations of Pulmonary Vascular Resistance as a Primary
Endpoint for Therapeutic Trials of Systemic Sclerosis
Associated Pulmonary Arterial Hypertension/R.T. Zamanian, R.
Rhee, A. Pinckney, E. Goldmuntz, B. Welch, C. D’Aveta, D.
Badesch, M. Nicolls, S.M. Kawut, M. Spychala, Stanford, CA,
p.A7366
Diagnostic Evaluation and Predictors of Prognosis in
Pulmonary Hypertension/M. Khalid, I. Weheba, S.M. Hassan,
A.M. Al Dalaan, A. Al Sugair, A. Abdelsayed, S. Saleemi, A.
Sheikh, M. Zeitouni, E. Al Mutairy, Riyadh, Saudi Arabia, p.A7367
Developing a Pulmonary Embolism Response Team (PERT) for
the treatment of Submassive Pulmoanry Embolism/D.M. Wisa, D.I.
Zapata, M. Walczyszyn, A. Conway, A. Tilley, A. Carroccio, R. Rosen,
S.J. Scheinerman, M. Weinberg, B. Mina, New York, NY, p.A7368
Evaluation of Quality of Care and Quality of Life of Pulmonary
Hypertension (PH) Patients Seen in PH Care Centers:
Pulmonary Hypertension Association Registry (PHAR) Study
Design/M.P. Gray, C.E. Ventetuolo, R. Oudiz, W. Hill, C. Pickles,
K. Blank, K. Williams, P.J. Leary, R. Kronmal, S.M. Kawut, Silver
Spring, MD, p.A7369
In Depth Analysis of Six Minute Walk Test Parameters in
Scleroderma Patients with and Without Pulmonary
Hypertension/A. Gadre, C. Ghattas, O.A. Minai, K.B. Highland,
Cleveland, OH, p.A7370
Pulmonary Function Phenotypes in Heart Failure with
Preserved Ejection Fraction (HFpEF)/N. Shea, M. Cuttica, R.
Kalhan, S. Shah, Chicago, IL, p.A7371
Genetic Counselling in a National Referral Centre for
Pulmonary Hypertension/B. Girerd, D. Montani, X. Jais, M.
Eyries, L. Savale, F. Parent, O. Sitbon, F. Soubrier, G. Simonneau,
M. Humbert, Le Kremlin Bicetre, France, p.A7372
Description of the Clinical, Functional and Hemodynamic
Characteristics of Patients with Pulmonary Arterial
Hypertension and Chronic Thromboembolic Pulmonary
Hypertension Treated with Intravenous Epoprostenol in
Colombia/C. Villaquiran-Torres, M. Orozco-Levi, A. Londono, J.
Ortega, J.E. Gomez, R. Conde, C. Borda, R. Duenas-Villamil,
Bogota, Colombia, p.A7373
Use of Treprostinil in Pregnant Women with Pulmonary
Arterial Hypertension During Peripartum Period/B. Liu, X.
Huang, W. Zhang, Z. Yu, Changsha, China, p.A7374
Comparison of Trans-Thoracic and Trans-Esophageal
Echocardiography in Measurement of Tricuspid Annular Plane
Systolic Excursion (TAPSE) to Diagnose Pulmonary
Hypertension/B.M. Buddhdev, K.B. Buddhdev, V. Mallavarapu,
Omaha, NE, p.A7375
C.D. Burger, MD, Jacksonville, FL
Right Heart Catheterism: Mandatory for Early Diagnosis of
Systemic Sclerosis Related Pulmonary Arterial
Hypertension/V.S. Vilela, M. Macri, A.A. Salgado, M. Castier, R.
Levy, E. Ferreira, C.H.D. Costa, R. Rufino, Rio de Janeiro, Brazil,
p.A7376
ATS 2016 • San Francisco